| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 6.18e-05 | 8 | 210 | 3 | GO:0015431 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCA1 MYO5A MYO5B MYO9A MCM5 DHX33 HELZ ABCC2 DNA2 DNAH5 ABCC1 DYNC2H1 ZNFX1 MSH2 ACSM2A ATP2B4 ACSM2B | 9.14e-05 | 614 | 210 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.30e-04 | 10 | 210 | 3 | GO:0043225 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | MYO5B SEMA3G FGF13 PLXNA2 DIP2B DSCAM XK GRIN1 TRAK1 PLXNC1 TRAK2 | 3.82e-06 | 192 | 206 | 11 | GO:0050770 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 6.28e-05 | 43 | 206 | 5 | GO:0098688 | |
| GeneOntologyCellularComponent | actin filament | 1.02e-04 | 146 | 206 | 8 | GO:0005884 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.16e-04 | 253 | 206 | 10 | GO:0030427 | |
| GeneOntologyCellularComponent | cytoplasmic region | HIF1A MYO5B GCK CFAP77 DNAH5 DYNC2H1 PCLO TRAK1 BBS7 TRAK2 SPAG17 CFAP53 | 2.51e-04 | 360 | 206 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | distal axon | MYO5A MYO9A SYNJ2 FGF13 USH2A DSCAM PTBP2 PCLO GRIN1 GRIN2A TRAK1 P2RX7 TRAK2 | 4.00e-04 | 435 | 206 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | USH2 complex | 5.72e-04 | 4 | 206 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | excitatory synapse | 6.74e-04 | 107 | 206 | 6 | GO:0060076 | |
| GeneOntologyCellularComponent | growth cone | 7.53e-04 | 245 | 206 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.31e-03 | 82 | 206 | 5 | GO:0032589 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.41e-03 | 6 | 206 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.41e-03 | 6 | 206 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.41e-03 | 6 | 206 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.41e-03 | 6 | 206 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.41e-03 | 6 | 206 | 2 | GO:1990075 | |
| Domain | Multidrug-R_assoc | 5.10e-06 | 4 | 204 | 3 | IPR005292 | |
| Domain | P-loop_NTPase | ABCC3 ABCA1 PNKP MYO5A MYO5B MYO9A LSG1 MCM5 DHX33 PFKFB4 SAMD9L ASPM HELZ ABCC2 DNA2 DNAH5 RAB6A ABCC1 DYNC2H1 ZNFX1 MSH2 RAB6B GFM1 RASD2 | 1.93e-05 | 848 | 204 | 24 | IPR027417 |
| Domain | Traffickng_kinesin-bd_prot_dom | 1.19e-04 | 2 | 204 | 2 | IPR022154 | |
| Domain | Milton | 1.19e-04 | 2 | 204 | 2 | PF12448 | |
| Domain | IPT | 1.99e-04 | 27 | 204 | 4 | SM00429 | |
| Domain | - | ABCC3 ABCA1 PNKP LSG1 MCM5 DHX33 PFKFB4 SAMD9L HELZ ABCC2 DNA2 DNAH5 RAB6A ABCC1 DYNC2H1 ZNFX1 MSH2 RAB6B GFM1 RASD2 | 2.04e-04 | 746 | 204 | 20 | 3.40.50.300 |
| Domain | TIG | 3.45e-04 | 31 | 204 | 4 | PF01833 | |
| Domain | RNA_pol_Rpb1_2 | 3.54e-04 | 3 | 204 | 2 | PF00623 | |
| Domain | RNA_pol_asu | 3.54e-04 | 3 | 204 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 3.54e-04 | 3 | 204 | 2 | IPR006592 | |
| Domain | RNA_pol_Rpb1_1 | 3.54e-04 | 3 | 204 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 3.54e-04 | 3 | 204 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 3.54e-04 | 3 | 204 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 3.54e-04 | 3 | 204 | 2 | PF05000 | |
| Domain | HAP1_N | 3.54e-04 | 3 | 204 | 2 | IPR006933 | |
| Domain | RPOLA_N | 3.54e-04 | 3 | 204 | 2 | SM00663 | |
| Domain | RNA_pol_Rpb1_4 | 3.54e-04 | 3 | 204 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 3.54e-04 | 3 | 204 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 3.54e-04 | 3 | 204 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 3.54e-04 | 3 | 204 | 2 | IPR007066 | |
| Domain | HAP1_N | 3.54e-04 | 3 | 204 | 2 | PF04849 | |
| Domain | IPT | 3.91e-04 | 32 | 204 | 4 | IPR002909 | |
| Domain | G8_domain | 7.02e-04 | 4 | 204 | 2 | IPR019316 | |
| Domain | G8 | 7.02e-04 | 4 | 204 | 2 | PS51484 | |
| Domain | G8 | 7.02e-04 | 4 | 204 | 2 | SM01225 | |
| Domain | G8 | 7.02e-04 | 4 | 204 | 2 | PF10162 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.11e-05 | 44 | 164 | 6 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.27e-05 | 45 | 164 | 6 | MM15694 | |
| Pubmed | PDE3B PNKP ILF2 MYO5A LSG1 PSMD3 MCM5 BIRC6 TTK BPNT2 PTPRC H4C1 GLE1 HELZ MVP DIP2B ABCC1 MAP7D3 COPB1 UBR4 MSH2 CIT POLR3A SCCPDH SLC16A1 PLXNC1 PRKAG1 NNT ATP2B4 | 1.59e-10 | 1168 | 212 | 29 | 19946888 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 ILF2 MYO5A MYO9A LSG1 MAT2A PSMD3 MCM5 DHX33 MCCC1 RRM1 BIRC6 GTF3C4 SERPINB6 H4C1 EIF2B4 ASPM SNX27 MVP COPB1 POLR2A UBR4 MSH2 POLR3A OXCT1 TFB1M SLC16A1 ASNS RIOK2 KDM1A | 1.08e-09 | 1353 | 212 | 30 | 29467282 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ILF2 MAT2A IRAK1 PSMD3 MCM5 DHX33 RRM1 BIRC6 GTF3C4 H4C1 HSD17B4 ALDH3A2 DNA2 CARM1 TBC1D15 COPB1 POLR2A UBR4 MSH2 FAS POLR3A ZNHIT6 SLC16A1 ASNS GFM1 KDM1A | 6.15e-08 | 1257 | 212 | 26 | 37317656 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MIS18BP1 MYO5A MYO9A MATN1 IRAK1 FUNDC1 DHX33 PFKFB4 ADCY9 MAP3K1 BPNT2 SYNJ2 GLE1 DHODH ASPM PLXNA2 DIP2B SLC25A20 GRB7 GRIN1 GRIN2A CIT GAS2L2 GFM1 CFAP53 | 1.88e-07 | 1242 | 212 | 25 | 30973865 |
| Pubmed | The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. | 2.23e-07 | 3 | 212 | 3 | 12628490 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 18799096 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 17494643 | ||
| Pubmed | 3.19e-07 | 45 | 212 | 6 | 25979088 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ILF2 PSMD3 MCM5 DHX33 BIRC6 GTF3C4 EIF2B4 SNX27 DNAH5 CARM1 COPB1 POLR2A UBR4 MSH2 POLR3A OXCT1 ASNS KDM1A | 3.80e-07 | 704 | 212 | 18 | 29955894 |
| Pubmed | ILF2 MAT2A IRAK1 PSMD3 MCM5 RRM1 HSD17B4 ALDH3A2 CARM1 TBC1D15 COPB1 PTBP2 POLR2A UBR4 MSH2 ASNS KDM1A | 4.59e-07 | 638 | 212 | 17 | 33239621 | |
| Pubmed | ILF2 MYO5A LSG1 DIAPH2 UNC79 CARM1 CNTN4 DIP2B RANBP10 DSCAM NACC1 UBR4 ZNFX1 GRIN1 GRIN2A CIT RPH3A P2RX7 OTUD4 ATP2B4 KDM1A | 5.36e-07 | 963 | 212 | 21 | 28671696 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 16946557 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 18038766 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 11937269 | ||
| Pubmed | ILF2 MCM5 BIRC6 SERPINB6 AMOT SNX27 HSD17B4 COPB1 POLR2A UBR4 MSH2 OXCT1 ASNS GFM1 NNT | 1.16e-06 | 534 | 212 | 15 | 35032548 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ABCC3 HIF1A RRM1 BRCA1 ABCC2 HSD17B4 ABCC1 COL12A1 CASP9 MSH2 REV3L FAS | 1.91e-06 | 351 | 212 | 12 | 20453000 |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 12435728 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 12576456 | ||
| Pubmed | PDE3B MAN2B1 LSG1 DIAPH2 HELZ DENND5A HSD17B4 DNA2 EPN1 DIP2B GRB7 ZNFX1 POLR3A CEMIP ZNHIT6 RIOK2 | 2.80e-06 | 650 | 212 | 16 | 38777146 | |
| Pubmed | 3.84e-06 | 18 | 212 | 4 | 32496646 | ||
| Pubmed | HIF1A MAN2B1 UGT3A1 TATDN2 BIRC6 BIRC8 DUSP6 SLC5A9 CASP9 FAS PRKAG1 | 3.97e-06 | 313 | 212 | 11 | 20800603 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 17283126 | ||
| Pubmed | HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution and transport. | 4.41e-06 | 6 | 212 | 3 | 19528298 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 12951053 | ||
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 9990849 | ||
| Pubmed | Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. | 7.68e-06 | 7 | 212 | 3 | 20922799 | |
| Pubmed | HDAC11 ILF2 MYO5A MYO5B MYO9A PSMD3 ELFN2 AMOT SYN2 SNX27 C1QB FGF13 COPB1 IGHV1-24 PCLO RBP3 ZNFX1 GRIN1 GRIN2A CIT RPH3A NUAK2 OTUD4 ATP2B4 | 7.84e-06 | 1431 | 212 | 24 | 37142655 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MAT2A IRAK1 PSMD3 MCM5 EIF2B4 SNX27 HELZ ALDH3A2 CARM1 DIP2B RANBP10 TBC1D15 UBR4 DUSP6 MSH2 ASNS DUSP10 GFM1 KDM1A | 9.37e-06 | 974 | 212 | 19 | 28675297 |
| Pubmed | MYO5A DHX33 ELFN2 ADCY9 SYN2 PCLO GRIN1 GRIN2A CIT SLC16A1 GABRA3 | 1.05e-05 | 347 | 212 | 11 | 17114649 | |
| Pubmed | 1.22e-05 | 8 | 212 | 3 | 15802388 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDE3B ILF2 FAM186B BIRC6 SAMD9L H4C1 AMOT SCN8A CARM1 NACC1 PCLO POLR2A UBR4 GRIN1 REV3L ASNS | 1.32e-05 | 736 | 212 | 16 | 29676528 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | PNKP ILF2 PSMD3 MCM5 DIP2B COPB1 PCLO POLR2A UBR4 MSH2 SCCPDH ASNS KDM1A | 1.33e-05 | 498 | 212 | 13 | 36634849 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIF1A PDE3B MYO5A MYO9A WDR25 PFKFB4 ADGRV1 PLEKHH1 SERPINB6 SYNJ2 EIF2B4 FGF13 PLCB4 DENND5A DIP2B BEST1 PTBP2 FRMPD2 RAB6B ADGRG6 RANBP17 NADSYN1 PRKAG1 HSD17B14 | 1.51e-05 | 1489 | 212 | 24 | 28611215 |
| Pubmed | 1.59e-05 | 130 | 212 | 7 | 12421765 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 MAN2B1 IRAK1 ELP6 MCM5 BIRC6 LYST ADCY9 SCN8A DIAPH2 DENND5A RANBP10 POLR2A UBR4 REV3L CIT TRAK1 NADSYN1 SLC45A3 RASD2 | 1.60e-05 | 1105 | 212 | 20 | 35748872 |
| Pubmed | 1.65e-05 | 52 | 212 | 5 | 26633812 | ||
| Pubmed | 1.83e-05 | 9 | 212 | 3 | 8788039 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ILF2 LSG1 MAT2A PSMD3 MCM5 H4C1 AMOT HSD17B4 ALDH3A2 DNAH5 TBC1D15 COPB1 DYNC2H1 PCLO POLR2A UBR4 MSH2 POLR3A SLC16A1 ASNS GFM1 NNT KDM1A | 2.24e-05 | 1425 | 212 | 23 | 30948266 |
| Pubmed | PDE3B MCM5 MCCC1 RRM1 BIRC6 ADCY9 SERPINB6 HSD17B4 ALDH3A2 EPN1 RAB6A ABCC1 MSH2 RAB6B SLC16A1 GFM1 NNT ATP2B4 | 2.45e-05 | 952 | 212 | 18 | 38569033 | |
| Pubmed | MYO5A PSMD3 MCCC1 BIRC6 ELFN2 SERPINB6 SYN2 HELZ PCLO UBR4 ZNFX1 GRIN1 GRIN2A RAB6B CIT RPH3A OXCT1 SLC16A1 UBR3 GFM1 | 2.46e-05 | 1139 | 212 | 20 | 36417873 | |
| Pubmed | MYO5A MYO5B PSMD3 BIRC6 ADCY9 PTPRC SNX27 HELZ HSD17B4 ALDH3A2 ABCC1 POLR2A DUSP6 MSH2 SCCPDH OTUD4 UBR3 DUSP10 ATP2B4 | 2.60e-05 | 1049 | 212 | 19 | 27880917 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | HDAC11 ILF2 GTF3C4 GLE1 EIF2B4 ASPM HELZ DNA2 PCLO OTUD4 SERAC1 KDM1A | 3.00e-05 | 462 | 212 | 12 | 31138677 |
| Pubmed | Maternal bile acid transporter deficiency promotes neonatal demise. | 3.08e-05 | 59 | 212 | 5 | 26416771 | |
| Pubmed | ILF2 MYO9A LSG1 MAT2A IRAK1 PSMD3 RRM1 TTK ADCY9 ALDH3A2 CARM1 TBC1D15 MAP7D3 COPB1 SLC16A1 | 3.32e-05 | 708 | 212 | 15 | 39231216 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 3.55e-05 | 11 | 212 | 3 | 26319580 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 23604598 | ||
| Pubmed | Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. | 3.70e-05 | 2 | 212 | 2 | 11266082 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 38830762 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 29464551 | ||
| Pubmed | IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma. | 3.70e-05 | 2 | 212 | 2 | 29031476 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 27421704 | ||
| Pubmed | Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis. | 3.70e-05 | 2 | 212 | 2 | 32269165 | |
| Pubmed | Hypoxia-independent mechanisms of HIF-1α expression in astrocytes after ischemic preconditioning. | 3.70e-05 | 2 | 212 | 2 | 28063215 | |
| Pubmed | Crystallization of an engineered RUN domain of Rab6-interacting protein 1/DENND5. | 3.70e-05 | 2 | 212 | 2 | 21543860 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 20230862 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 33969428 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 28126851 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 16476413 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25653102 | ||
| Pubmed | TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis. | 3.70e-05 | 2 | 212 | 2 | 28655204 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 34638692 | ||
| Pubmed | EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC. | 3.70e-05 | 2 | 212 | 2 | 30665327 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25788542 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25078585 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 21460102 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 34193509 | ||
| Pubmed | AMPK interacts with DSCAM and plays an important role in netrin-1 induced neurite outgrowth. | 3.70e-05 | 2 | 212 | 2 | 23479427 | |
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 3.70e-05 | 2 | 212 | 2 | 28653555 | |
| Pubmed | The second PDZ domain of scaffold protein Frmpd2 binds to GluN2A of NMDA receptors. | 3.70e-05 | 2 | 212 | 2 | 31196628 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 18990687 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 19949104 | ||
| Pubmed | Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. | 3.70e-05 | 2 | 212 | 2 | 11745434 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25609945 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 9721050 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 27583302 | ||
| Pubmed | MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1. | 3.70e-05 | 2 | 212 | 2 | 36894311 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 30951900 | ||
| Pubmed | The interleukin-1 receptor associated kinase 1 contributes to the regulation of NFAT. | 3.70e-05 | 2 | 212 | 2 | 18691762 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 19088030 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 29948332 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 28095420 | ||
| Pubmed | Regulatory T cells are resistant to apoptosis via TCR but not P2X7. | 3.70e-05 | 2 | 212 | 2 | 17339442 | |
| Pubmed | The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein. | 3.70e-05 | 2 | 212 | 2 | 16123590 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 35831562 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 10742052 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 30710214 | ||
| Pubmed | Structural Basis of the Proton Sensitivity of Human GluN1-GluN2A NMDA Receptors. | 3.70e-05 | 2 | 212 | 2 | 30590034 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 17606722 | ||
| Pubmed | MCT1 promotes the cisplatin-resistance by antagonizing Fas in epithelial ovarian cancer. | 3.70e-05 | 2 | 212 | 2 | 26045776 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 33436551 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 11279200 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25060527 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 23284917 | ||
| Pubmed | ASPM and citron kinase co-localize to the midbody ring during cytokinesis. | 3.70e-05 | 2 | 212 | 2 | 17534152 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 24739903 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 28262924 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 16091456 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 19969624 | ||
| Pubmed | Fas-dependent elimination of nonselected CD8 cells and lpr disease. | 3.70e-05 | 2 | 212 | 2 | 11994447 | |
| Pubmed | High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. | 3.70e-05 | 2 | 212 | 2 | 18030615 | |
| Interaction | EGLN3 interactions | HIF1A PDE3B LSG1 TATDN2 IRAK1 PSMD3 MCM5 RRM1 MCRIP1 BIRC6 TTK GTF3C4 BRCA1 AMOT ASPM HELZ HSD17B4 CARM1 RANBP10 EGLN2 TBC1D15 MAP7D3 COPB1 POLR2A UBR4 MSH2 POLR3A ZNHIT6 SLC16A1 OTUD4 GFM1 RIOK2 KDM1A | 9.68e-07 | 1296 | 205 | 33 | int:EGLN3 |
| Interaction | SQSTM1 interactions | HIF1A PNKP ILF2 MYO5A MAT2A IRAK1 PSMD3 FUNDC1 DHX33 RRM1 TTK BRCA1 SYNJ2 AMOT HELZ EPN1 RAB6A PADI1 CARM1 DIP2B TBC1D15 MAP7D3 CASP9 FAS CIT SCCPDH SLC16A1 ASNS OTUD4 KDM1A | 1.15e-05 | 1257 | 205 | 30 | int:SQSTM1 |
| GeneFamily | Fibronectin type III domain containing | 3.33e-05 | 160 | 139 | 8 | 555 | |
| GeneFamily | UPF1 like RNA helicases | 7.01e-05 | 11 | 139 | 3 | 1169 | |
| GeneFamily | ATP binding cassette subfamily C | 1.20e-04 | 13 | 139 | 3 | 807 | |
| GeneFamily | Myosins, class V | 1.75e-04 | 3 | 139 | 2 | 1100 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 3.49e-04 | 4 | 139 | 2 | 1244 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.20e-03 | 7 | 139 | 2 | 785 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.20e-03 | 7 | 139 | 2 | 1201 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 1.59e-03 | 8 | 139 | 2 | 419 | |
| GeneFamily | MCM family | 2.04e-03 | 9 | 139 | 2 | 1085 | |
| GeneFamily | Plexins | 2.04e-03 | 9 | 139 | 2 | 683 | |
| GeneFamily | MAP kinase phosphatases | 3.08e-03 | 11 | 139 | 2 | 895 | |
| GeneFamily | Immunoglobulin like domain containing | 3.81e-03 | 193 | 139 | 6 | 594 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYO5A TATDN2 DHX33 LYST FRMD4B TBC1D32 NLN KIAA1549L SCN8A SYN2 PLCB4 UNC79 CNTN4 DIP2B THSD7A DSCAM COL6A6 PCLO XK REV3L CCDC141 SLC4A3 CEMIP PLXNC1 ASNS OTUD4 SPAG17 | 2.05e-07 | 1106 | 207 | 27 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ELFN2 FRMD4B TBC1D32 NLN KIAA1549L SCN8A SYN2 FGF13 PLCB4 UNC79 PLXNA2 CNTN4 DSCAM PCLO REV3L RAB6B SLC4A3 FAR2 ASNS | 3.48e-06 | 703 | 207 | 19 | M39070 |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | MYO5B GCK DTX3L DIAPH2 DNAH5 EPS8L2 PTBP2 REV3L ADGRG6 GAS2L2 | 4.64e-06 | 200 | 207 | 10 | M7776 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.89e-05 | 187 | 207 | 9 | M2984 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_DN | 3.22e-05 | 200 | 207 | 9 | M5595 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.22e-05 | 200 | 207 | 9 | M6993 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | MIS18BP1 RRM1 ITGA9 TTK BRCA1 ASPM ALPK3 PLCB4 DNA2 XK TEK RANBP17 PLXNC1 ASNS ATP2B4 | 8.53e-06 | 410 | 200 | 15 | GSM791122_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PDE3B MIS18BP1 MYO9A ESRP1 MCM5 MCMDC2 TTK LYST BRCA1 SNX27 HELZ FGF13 DNA2 MSH2 RAB6B RANBP17 SCCPDH TFB1M ASNS OTUD4 PRSS42P | 3.33e-05 | 820 | 200 | 21 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | MIS18BP1 RRM1 TTK BRCA1 ASPM PLCB4 DNA2 ASAH2 XK TEK RANBP17 PLXNC1 ASNS ATP2B4 | 5.13e-05 | 423 | 200 | 14 | GSM791126_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | MIS18BP1 IRAK1 ADGRV1 BIRC6 PLEKHH1 TBC1D32 NLN KIAA1549L H4C1 ASPM PLCB4 RAB6A SLC25A20 THSD7A MAP7D3 PTBP2 PCLO GRB7 XK POLR3A NUAK2 RANBP17 PLXNC1 | 6.62e-05 | 994 | 200 | 23 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.63e-05 | 149 | 200 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 9.47e-05 | 78 | 200 | 6 | GSM605853_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | MIS18BP1 MCM5 RRM1 TTK BRCA1 ASPM FGF13 DNA2 RAG2 FAS CIT SLC16A1 DUSP10 | 1.09e-04 | 398 | 200 | 13 | GSM399397_500 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | MIS18BP1 HLA-DOB MCM5 RRM1 TTK BRCA1 ASPM DNA2 RAG2 GRB7 SLC16A1 NNT ATP2B4 | 1.17e-04 | 401 | 200 | 13 | GSM399450_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | PLAC1 ABCC3 ABCA1 MAN2B1 ELP6 DTX3L SEMA3G F8 FRMD4B SAMD9L PTPRC C1QB EXOC3L1 DNA2 DUSP6 TEK P2RX7 ATP2B4 SLC25A45 | 1.17e-04 | 764 | 200 | 19 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | PLAC1 MYO5B MYO9A MCCC1 SERPINB6 ALDH3A2 COL12A1 MAP7D3 ANPEP REV3L SLC4A3 PLXNC1 ASNS | 1.26e-04 | 404 | 200 | 13 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 1.28e-04 | 52 | 200 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_500 | ABCC3 MYO5B SEMA3G F8 PTPRC SCN8A C1QB CNTN4 THSD7A TEK RAB6B BBS7 ACSM2A | 1.64e-04 | 415 | 200 | 13 | gudmap_developingKidney_e15.5_Podocyte cells_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 1.75e-04 | 165 | 200 | 8 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PLAC1 MYO5B MYO9A MCCC1 F8 FRMD4B SERPINB6 ALDH3A2 PLXNA2 CNTN4 ABCC1 SLC25A20 COL12A1 MAP7D3 ANPEP REV3L SLC4A3 PLXNC1 ASNS | 1.83e-04 | 791 | 200 | 19 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | PLAC1 MYO5B MYO9A MCRIP1 FRMD4B SERPINB6 AMOT PLXNA2 CNTN4 SLC25A20 COL12A1 MAP7D3 ANPEP NACC1 CCDC141 SLC4A3 PLXNC1 ASNS RIOK2 | 2.02e-04 | 797 | 200 | 19 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_1000 | PLAC1 ABCC3 ABCA1 MAN2B1 DTX3L F8 FRMD4B PTPRC C1QB DUSP6 TEK P2RX7 ATP2B4 | 2.32e-04 | 430 | 200 | 13 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_1000 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | ABCC3 ABCA1 MAN2B1 MYO5A FRMD4B SERPINB6 SNX27 C1QB ANPEP ADGRG6 P2RX7 PLXNC1 SLC38A6 | 2.71e-04 | 437 | 200 | 13 | GSM605865_500 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | GGA2 MIS18BP1 HLA-DOB MCM5 RRM1 TTK BRCA1 ASPM DNA2 XK FAS ASNS | 2.72e-04 | 380 | 200 | 12 | GSM538207_500 |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | IRAK1 H4C1 NFATC4 C1QB DENND5A UBR4 SCCPDH ANO7 HSD17B14 SLC38A6 | 1.20e-08 | 174 | 212 | 10 | d77fa525d5c87c190b4a10787b270eabd16c610f |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.39e-07 | 190 | 212 | 9 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-07 | 195 | 212 | 9 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-07 | 198 | 212 | 9 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-07 | 198 | 212 | 9 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 5.22e-07 | 200 | 212 | 9 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 169 | 212 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.38e-06 | 179 | 212 | 8 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.48e-06 | 180 | 212 | 8 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 181 | 212 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 183 | 212 | 8 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.87e-06 | 129 | 212 | 7 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 3.30e-06 | 187 | 212 | 8 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.30e-06 | 187 | 212 | 8 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 188 | 212 | 8 | 61ae7405ab56570409bf35382dc0a038e4137c15 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 3.57e-06 | 189 | 212 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.57e-06 | 189 | 212 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.57e-06 | 189 | 212 | 8 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 190 | 212 | 8 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 191 | 212 | 8 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 191 | 212 | 8 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 193 | 212 | 8 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.16e-06 | 193 | 212 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 4.16e-06 | 193 | 212 | 8 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.16e-06 | 193 | 212 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.66e-06 | 196 | 212 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.84e-06 | 197 | 212 | 8 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.84e-06 | 197 | 212 | 8 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.84e-06 | 197 | 212 | 8 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 199 | 212 | 8 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 199 | 212 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 199 | 212 | 8 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 199 | 212 | 8 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.41e-06 | 200 | 212 | 8 | 0cf7208eab0dc58fbea35e256c5cb55cdd4a4928 | |
| ToppCell | severe-T/NK_proliferative|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.41e-06 | 200 | 212 | 8 | 9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 158 | 212 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 158 | 212 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-05 | 162 | 212 | 7 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 162 | 212 | 7 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 165 | 212 | 7 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 165 | 212 | 7 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 168 | 212 | 7 | de1042267407719f19eb3f580a5df0c9cd0e8273 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 1.69e-05 | 169 | 212 | 7 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 170 | 212 | 7 | 067657ca7fcf5a0ffbd168b5c4609a30ca508f22 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 173 | 212 | 7 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 173 | 212 | 7 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | facs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 174 | 212 | 7 | 54166a0faf748cccb6406c2c268e1e6e21caf6d0 | |
| ToppCell | facs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 174 | 212 | 7 | dc8a238ec1d954bec0f8eb67c04a61734c96f5b5 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 174 | 212 | 7 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 174 | 212 | 7 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | facs-Heart-LV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 175 | 212 | 7 | 5d106ef542b97f97aeb19179e3f72963ead1e82a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 175 | 212 | 7 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.11e-05 | 175 | 212 | 7 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 175 | 212 | 7 | 53e6f1f8dd482dfa2539e068dacefbb6e08443bc | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.11e-05 | 175 | 212 | 7 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 177 | 212 | 7 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 177 | 212 | 7 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.36e-05 | 178 | 212 | 7 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-05 | 178 | 212 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-05 | 179 | 212 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-05 | 179 | 212 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 180 | 212 | 7 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.53e-05 | 180 | 212 | 7 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.53e-05 | 180 | 212 | 7 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.53e-05 | 180 | 212 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.62e-05 | 122 | 212 | 6 | dba1c647172a11381efcb178a23808161908daa3 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.62e-05 | 181 | 212 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 181 | 212 | 7 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.62e-05 | 181 | 212 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 181 | 212 | 7 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 181 | 212 | 7 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 182 | 212 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 183 | 212 | 7 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 183 | 212 | 7 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-05 | 184 | 212 | 7 | 1a4297b9d3cc4744bea0408fd5ee7b33ba2a1d78 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 2.91e-05 | 184 | 212 | 7 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 185 | 212 | 7 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-05 | 185 | 212 | 7 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.02e-05 | 185 | 212 | 7 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 185 | 212 | 7 | eeb6f55a6f79adf80247baa2c4b0df44553557ad | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 185 | 212 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 3.02e-05 | 185 | 212 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.02e-05 | 185 | 212 | 7 | a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.12e-05 | 186 | 212 | 7 | 799903b68bc6f6205d004b44c603424b0d5f7c32 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 186 | 212 | 7 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 187 | 212 | 7 | 6288da8cdd450c58df00ebcfcc118f01fab7e610 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 187 | 212 | 7 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 3.23e-05 | 187 | 212 | 7 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 187 | 212 | 7 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-05 | 187 | 212 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.23e-05 | 187 | 212 | 7 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 127 | 212 | 6 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 188 | 212 | 7 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 3.34e-05 | 188 | 212 | 7 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-05 | 188 | 212 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.34e-05 | 188 | 212 | 7 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 188 | 212 | 7 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| Drug | magnesium | PDE3B PNKP MAN2B1 MYO5A MYO5B MAT2A GCK MCCC1 PFKFB4 ADGRV1 RRM1 ITGA9 ADCY9 CKMT2 DENND5A ALDH3A2 DNAH5 RAG2 ABCC1 ANPEP POLR2A MSH2 GRIN1 GRIN2A RAB6B RPH3A NADSYN1 P2RX7 PRKAG1 HSD17B14 GFM1 NNT ATP2B4 | 2.06e-07 | 1325 | 211 | 33 | CID000000888 |
| Drug | 5-carboxyfluorescein diacetate | 7.85e-07 | 3 | 211 | 3 | ctd:C084577 | |
| Drug | Frie Mao 1-43 | 1.52e-06 | 61 | 211 | 7 | CID002733618 | |
| Drug | dioxane | ABCC3 PSMD3 CKMT2 DIAPH2 SYN2 ABCC2 EPN1 MVP RAB6A ABCC1 CASP9 FAS THRSP | 2.14e-06 | 278 | 211 | 13 | CID000031275 |
| Drug | N-acetyldopamine | 2.98e-06 | 25 | 211 | 5 | CID000100526 | |
| Drug | tetramethylrosamine | 6.67e-06 | 14 | 211 | 4 | CID000443313 | |
| Drug | AMP group | PLAC1 PDE3B ILF2 GCK MCCC1 RRM1 ADCY9 ALDH3A2 CARM1 SIRT6 FAS NADSYN1 P2RX7 ASNS PRKAG1 ACSM2A NNT ACSM2B | 8.24e-06 | 579 | 211 | 18 | CID000000224 |
| Drug | PAK-104P | 9.03e-06 | 15 | 211 | 4 | CID000131368 | |
| Drug | pyruvic acid | HIF1A MAT2A PSMD3 GCK MCCC1 PFKFB4 ADCY9 CKMT2 DHODH ALDH3A2 OXCT1 FAR2 SLC16A1 GFM1 NNT | 1.07e-05 | 424 | 211 | 15 | CID000001060 |
| Drug | glutathione reduced | ABCC3 PNKP MAT2A RRM1 LYST CKMT2 ABCC2 ALDH3A2 MVP ABCC1 ANPEP CASP9 GRIN2A FAS ARR3 NNT SLC38A6 | 1.09e-05 | 534 | 211 | 17 | CID000000745 |
| Drug | AC1L1GTT | HDAC11 IRAK1 ADCY9 NFATC4 SYN2 HSD17B4 GRB7 GRIN2A GRM6 P2RX7 ATP2B4 | 1.20e-05 | 233 | 211 | 11 | CID000003837 |
| Drug | dichloromethanediamine | ABCC3 HIF1A ABCA1 RRM1 MAP3K1 BRCA1 ASPM ABCC2 MVP ABCC1 BIRC8 EPS8L2 POLR2A CASP9 MSH2 REV3L FAS | 1.23e-05 | 539 | 211 | 17 | CID005311048 |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.48e-05 | 195 | 211 | 10 | 4794_UP | |
| Drug | AC1NB6SN | 1.54e-05 | 6 | 211 | 3 | CID004488324 | |
| Drug | antibiotic G 418 | 1.55e-05 | 17 | 211 | 4 | ctd:C010680 | |
| Drug | fluo-3 | 1.86e-05 | 122 | 211 | 8 | CID000104978 | |
| Drug | hydroxyl radicals | PDE3B PNKP GCK MCCC1 PFKFB4 RRM1 F8 PTPRC SYNJ2 DHODH PLCB4 HSD17B4 ALDH3A2 PADI1 ABCC1 SLC25A20 ANPEP DUSP6 RBP3 CASP9 XK FAS CIT NADSYN1 ASNS DUSP10 SPAG17 GFM1 ATP2B4 | 1.87e-05 | 1341 | 211 | 29 | CID000000961 |
| Drug | Calcein AM | 2.35e-05 | 62 | 211 | 6 | CID000390986 | |
| Drug | adenine | ABCC3 MAT2A GCK RRM1 ADCY9 CKMT2 CARM1 ABCC1 XK MSH2 SIRT6 REV3L NADSYN1 TFB1M P2RX7 NNT | 2.38e-05 | 510 | 211 | 16 | CID000000190 |
| Drug | butyrate | HDAC11 HIF1A MAT2A LYST ADCY9 H4C1 MVP POLR2A RBP3 CASP9 MUC12 SIRT6 REV3L FAS OXCT1 SLC16A1 MUC5AC ATP2B4 KDM1A GABRA3 | 3.29e-05 | 767 | 211 | 20 | CID000000264 |
| Drug | calcein AM | 4.25e-05 | 8 | 211 | 3 | ctd:C085925 | |
| Drug | nicotine glucuronide | 4.25e-05 | 8 | 211 | 3 | CID003035848 | |
| Drug | 3',4',7-trihydroxyisoflavone | 4.25e-05 | 8 | 211 | 3 | ctd:C061213 | |
| Drug | m189 | 4.43e-05 | 178 | 211 | 9 | CID000022230 | |
| Drug | AC1Q5X3R | 4.60e-05 | 22 | 211 | 4 | CID000108075 | |
| Drug | Ozone | ABCA1 PDE3B MIS18BP1 MCM5 GCK PFKFB4 RRM1 TTK CKMT2 PTPRC BRCA1 ASPM MVP PLXNA2 ABCC1 CASP9 MSH2 GRIN1 GRIN2A TEK FAS THRSP FAR2 SLC16A1 DUSP10 MUC5AC CFAP53 | 5.19e-05 | 1273 | 211 | 27 | ctd:D010126 |
| Drug | Glutathione Disulfide | 5.53e-05 | 23 | 211 | 4 | ctd:D019803 | |
| Drug | nobiletin | 5.53e-05 | 23 | 211 | 4 | ctd:C008661 | |
| Drug | hydroxyrubicin | 5.53e-05 | 23 | 211 | 4 | CID000072398 | |
| Drug | orthovanadate | ABCC3 ABCA1 PDE3B GCK PFKFB4 ADCY9 PTPRC ALPK3 ABCC1 COPB1 DUSP6 SIRT6 FAS ATP2B4 | 5.91e-05 | 435 | 211 | 14 | CID000061672 |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 6.77e-05 | 188 | 211 | 9 | 7124_UP | |
| Drug | Epirubicin | 7.29e-05 | 47 | 211 | 5 | ctd:D015251 | |
| Drug | Tocopherols | 8.09e-05 | 77 | 211 | 6 | ctd:D024505 | |
| Drug | 5(6)-carboxy-2',7'-dichlorofluorescein | 8.55e-05 | 2 | 211 | 2 | ctd:C053897 | |
| Drug | Sulfinpyrazone | 8.55e-05 | 2 | 211 | 2 | DB01138 | |
| Drug | glutathione-BPDE conjugate | 8.55e-05 | 2 | 211 | 2 | ctd:C113118 | |
| Drug | robinetin | 8.55e-05 | 2 | 211 | 2 | ctd:C040014 | |
| Drug | Fluo-3 | 8.55e-05 | 2 | 211 | 2 | ctd:C059715 | |
| Drug | E3040 glucuronide | 8.55e-05 | 2 | 211 | 2 | CID000443294 | |
| Drug | Carboplatin | 8.95e-05 | 113 | 211 | 7 | ctd:D016190 | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 3451_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 8.96e-05 | 195 | 211 | 9 | 4557_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 9.69e-05 | 197 | 211 | 9 | 3838_DN | |
| Drug | mitoxantrone | 9.77e-05 | 154 | 211 | 8 | CID000004212 | |
| Drug | retinoic acid; Down 200; 1uM; PC3; HT_HG-U133A | 1.01e-04 | 198 | 211 | 9 | 4435_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.05e-04 | 199 | 211 | 9 | 2220_DN | |
| Disease | Peripheral Nervous System Diseases | 1.82e-06 | 54 | 201 | 6 | C4721453 | |
| Disease | varicocele (biomarker_via_orthology) | 6.13e-06 | 6 | 201 | 3 | DOID:12337 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 9.56e-06 | 108 | 201 | 7 | DOID:684 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.70e-05 | 8 | 201 | 3 | DOID:1561 (biomarker_via_orthology) | |
| Disease | X-21319 measurement | 4.62e-05 | 2 | 201 | 2 | EFO_0800807 | |
| Disease | Bipolar Disorder | HIF1A ITGA9 SCN8A CNTN4 THSD7A DSCAM PCLO DUSP6 GRIN1 GRIN2A P2RX7 GABRA3 | 1.15e-04 | 477 | 201 | 12 | C0005586 |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.33e-04 | 15 | 201 | 3 | DOID:3146 (implicated_via_orthology) | |
| Disease | X-11478 measurement | 1.38e-04 | 3 | 201 | 2 | EFO_0021242 | |
| Disease | phenylalanylphenylalanine measurement | 1.38e-04 | 3 | 201 | 2 | EFO_0021131 | |
| Disease | carbohydrate measurement | 2.73e-04 | 46 | 201 | 4 | EFO_0004998 | |
| Disease | uric acid measurement | ABCA1 MYO9A ADGRV1 BIRC6 ADCY9 PLEKHH1 CNTN4 DSCAM DYNC2H1 SLC5A9 RPH3A CEMIP ACSM2B | 3.04e-04 | 610 | 201 | 13 | EFO_0004761 |
| Disease | gastric ulcer (biomarker_via_orthology) | 3.78e-04 | 21 | 201 | 3 | DOID:10808 (biomarker_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.93e-04 | 139 | 201 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Anoxic-Ischemic Encephalopathy | 4.56e-04 | 5 | 201 | 2 | C0752305 | |
| Disease | Hypoxic-Ischemic Encephalopathy | 4.56e-04 | 5 | 201 | 2 | C0752304 | |
| Disease | Anoxia-Ischemia, Cerebral | 4.56e-04 | 5 | 201 | 2 | C0752307 | |
| Disease | Anoxia-Ischemia, Brain | 4.56e-04 | 5 | 201 | 2 | C0752306 | |
| Disease | Hypoxia-Ischemia, Brain | 4.56e-04 | 5 | 201 | 2 | C0752308 | |
| Disease | Cerebral Hypoxia-Ischemia | 4.56e-04 | 5 | 201 | 2 | C0178540 | |
| Disease | seasonality measurement, vitamin D measurement | 4.56e-04 | 5 | 201 | 2 | EFO_0004631, EFO_0006876 | |
| Disease | 3-hydroxyhexanoate measurement | 4.56e-04 | 5 | 201 | 2 | EFO_0800378 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.92e-04 | 145 | 201 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | ecosanoids measurement | 5.43e-04 | 55 | 201 | 4 | EFO_0020044 | |
| Disease | VACTERL association (implicated_via_orthology) | 6.80e-04 | 6 | 201 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | indoleacetoylcarnitine measurement | 6.80e-04 | 6 | 201 | 2 | EFO_0800106 | |
| Disease | indolepropionate measurement | 6.80e-04 | 6 | 201 | 2 | EFO_0021016 | |
| Disease | Adult only | 6.80e-04 | 6 | 201 | 2 | C3842001 | |
| Disease | dry eye syndrome (implicated_via_orthology) | 6.80e-04 | 6 | 201 | 2 | DOID:10140 (implicated_via_orthology) | |
| Disease | brain ischemia (biomarker_via_orthology) | 6.81e-04 | 102 | 201 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | response to opioid | 8.05e-04 | 61 | 201 | 4 | EFO_0008541 | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 9.48e-04 | 7 | 201 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | Ciliopathies | 9.57e-04 | 110 | 201 | 5 | C4277690 | |
| Disease | Colorectal Carcinoma | ABCC3 ABCA1 CFAP77 ABCC2 CNTN4 ABCC1 FRMPD2 RBP3 MSH2 GRIN2A ZNHIT6 P2RX7 SPAG17 | 1.12e-03 | 702 | 201 | 13 | C0009402 |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.12e-03 | 301 | 201 | 8 | DOID:684 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | HIF1A DTX3L PFKFB4 ITGA9 MAP3K1 PTPRC BRCA1 H4C1 SYNJ2 C1QB EXOC3L1 ABCC1 DYNC2H1 UBR4 GRB7 TEK GRM6 | 1.15e-03 | 1074 | 201 | 17 | C0006142 |
| Disease | QT interval | ELP6 FRMD4B RNF150 ALPK3 ABCC1 SLC25A20 CCDC141 SLC4A3 TRAK1 FAR2 SLC16A1 | 1.16e-03 | 534 | 201 | 11 | EFO_0004682 |
| Disease | placental insufficiency (biomarker_via_orthology) | 1.26e-03 | 8 | 201 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | Familial hyperinsulinism | 1.26e-03 | 8 | 201 | 2 | cv:C3888018 | |
| Disease | Hematological Disease | 1.26e-03 | 8 | 201 | 2 | C0018939 | |
| Disease | pregnanediol-3-glucuronide measurement | 1.26e-03 | 8 | 201 | 2 | EFO_0800341 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.46e-03 | 33 | 201 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.46e-03 | 33 | 201 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | heart function measurement | 1.59e-03 | 34 | 201 | 3 | EFO_0004311 | |
| Disease | Erythrocytosis familial, 1 | 1.61e-03 | 9 | 201 | 2 | C4551637 | |
| Disease | pre-malignant neoplasm (implicated_via_orthology) | 1.61e-03 | 9 | 201 | 2 | DOID:0060071 (implicated_via_orthology) | |
| Disease | metabolite measurement | ABCC3 UGT3A1 MCCC1 ABCC2 ABCC1 DSCAM SLC5A9 CASP9 REV3L HSD17B14 ACSM2A | 1.69e-03 | 560 | 201 | 11 | EFO_0004725 |
| Disease | visceral adipose tissue measurement | ABCA1 MCMDC2 ADCY9 H4C1 HELZ UNC79 DUSP6 GRIN2A RANBP17 FANK1 | 1.80e-03 | 481 | 201 | 10 | EFO_0004765 |
| Disease | urinary bladder cancer (is_implicated_in) | 1.83e-03 | 76 | 201 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | Mental Depression | 1.86e-03 | 254 | 201 | 7 | C0011570 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 2.00e-03 | 10 | 201 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | interleukin 10 measurement | 2.01e-03 | 78 | 201 | 4 | EFO_0004750 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.04e-03 | 37 | 201 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | vitamin D deficiency | 2.04e-03 | 37 | 201 | 3 | EFO_0003762 | |
| Disease | serum metabolite measurement | UGT3A1 GCK MCCC1 ABCC2 CNTN4 ABCC1 CASP9 REV3L TEK RAB6B CIT OTUD4 ACSM2A ACSM2B SLC25A45 | 2.17e-03 | 945 | 201 | 15 | EFO_0005653 |
| Disease | hepatocyte growth factor-like protein measurement | 2.20e-03 | 38 | 201 | 3 | EFO_0008154 | |
| Disease | Nonsyndromic Deafness | 2.31e-03 | 81 | 201 | 4 | C3711374 | |
| Disease | HbA1c measurement | MATN1 GCK ADCY9 H4C1 EIF2B4 SYN2 DIP2B ABCC1 ATP11AUN RPH3A PRKAG1 ATP2B4 | 2.41e-03 | 675 | 201 | 12 | EFO_0004541 |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 2.44e-03 | 11 | 201 | 2 | 146110 | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 2.44e-03 | 11 | 201 | 2 | cv:C0342384 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.44e-03 | 11 | 201 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 2.44e-03 | 11 | 201 | 2 | DOID:8725 (is_marker_for) | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 2.44e-03 | 11 | 201 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0800279 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 2.91e-03 | 12 | 201 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | Autoimmune Diseases | 2.94e-03 | 42 | 201 | 3 | C0004364 | |
| Disease | immunoglobulin isotype switching measurement | 3.36e-03 | 44 | 201 | 3 | EFO_0010128 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.38e-03 | 90 | 201 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | Disorder of eye | 3.42e-03 | 212 | 201 | 6 | C0015397 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 3.43e-03 | 13 | 201 | 2 | EFO_0800474 | |
| Disease | X-24588 measurement | 3.43e-03 | 13 | 201 | 2 | EFO_0800898 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.58e-03 | 45 | 201 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | tuberculosis | 3.74e-03 | 216 | 201 | 6 | MONDO_0018076 | |
| Disease | Heart Diseases | 3.81e-03 | 46 | 201 | 3 | C0018799 | |
| Disease | beta-hydroxyisovalerate measurement | 3.98e-03 | 14 | 201 | 2 | EFO_0800125 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 3.98e-03 | 14 | 201 | 2 | DOID:627 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome (is_marker_for) | 4.05e-03 | 47 | 201 | 3 | DOID:2945 (is_marker_for) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 4.51e-03 | 157 | 201 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | vitamin D measurement, COVID-19 | 4.56e-03 | 49 | 201 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | Down syndrome (implicated_via_orthology) | 4.57e-03 | 15 | 201 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Generalized hypotonia | 4.57e-03 | 15 | 201 | 2 | C1858120 | |
| Disease | Situs ambiguus | 4.57e-03 | 15 | 201 | 2 | C0266642 | |
| Disease | periprosthetic osteolysis, disease progression measurement | 4.57e-03 | 15 | 201 | 2 | EFO_0008336, EFO_0009761 | |
| Disease | hearing impairment | 4.59e-03 | 98 | 201 | 4 | C1384666 | |
| Disease | cognitive inhibition measurement | 4.82e-03 | 50 | 201 | 3 | EFO_0007969 | |
| Disease | Disease Exacerbation | 5.56e-03 | 165 | 201 | 5 | C0235874 | |
| Disease | nervous system disorder | 5.68e-03 | 53 | 201 | 3 | C0027765 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 5.87e-03 | 17 | 201 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | partial epilepsy | 5.87e-03 | 17 | 201 | 2 | EFO_0004263 | |
| Disease | X-21441 measurement | 5.87e-03 | 17 | 201 | 2 | EFO_0800814 | |
| Disease | plasminogen activator inhibitor 1 measurement | 5.98e-03 | 54 | 201 | 3 | EFO_0004792 | |
| Disease | diabetic retinopathy (is_marker_for) | 5.98e-03 | 54 | 201 | 3 | DOID:8947 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 6.14e-03 | 169 | 201 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 6.57e-03 | 18 | 201 | 2 | C0342384 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITTVRASVGMYLISK | 336 | P08243 | |
| SRLKSVMQSYLEGVQ | 66 | Q86VI1 | |
| LQIGTYANIAMVRTT | 196 | P54619 | |
| YMGVTSLSGIQLSQR | 1116 | P48751 | |
| NRMDYLQVGVTSQKT | 6 | Q8IWZ6 | |
| FYVTGVTNQKMRTEG | 131 | Q4VCS5 | |
| GDQLRTMTYTIVLNS | 376 | Q8IYS0 | |
| QQAITTKISYEIGLM | 146 | Q9H305 | |
| YIAMNRGAVKAGLVT | 156 | Q6ZQR2 | |
| MKITVIGRYGSTNAR | 1856 | Q9NR09 | |
| SSVQQLGIKMTVRYG | 1006 | Q96NH3 | |
| QRKTLVSYVMACSIG | 761 | Q86SQ4 | |
| GTIQMKSTDILYRLQ | 136 | Q08AH3 | |
| ILMVTSGGYQKRTAR | 296 | Q96DB2 | |
| RVLTGTEKKTGVYMQ | 606 | O95477 | |
| ENLIYGIMLRKSSVT | 3276 | Q8WXG9 | |
| KMTDVQIATKLRGYQ | 1781 | Q96L96 | |
| AGKYVCMVQTSVDRL | 571 | Q8IWV2 | |
| IFYTGNTAVGKIVME | 181 | P51648 | |
| QSSRGIKVEGCVRMY | 121 | Q53GS7 | |
| MTITYTSQVANARLG | 1 | O76090 | |
| SEYMEGNVRKVVATT | 196 | P15144 | |
| SGKVVRVMLDYVDQV | 491 | A6NK59 | |
| YSIVGQKLGVSLTMA | 61 | Q0PNE2 | |
| SKGEVRAIRYMATVV | 226 | Q8IYM0 | |
| REMVVQYISATAKSG | 136 | O60879 | |
| NSIVLMASKGRYVSR | 1286 | Q8WUJ3 | |
| VQVVREKATGDIYAM | 111 | O14578 | |
| KAAVVTLQSAYRGMK | 2021 | Q8IZT6 | |
| VSYKVRVNLMVSCGG | 316 | P36575 | |
| TMNRMTVVQAYIGGI | 471 | P23634 | |
| RMQGLAYNTGVKEIL | 636 | Q6NXG1 | |
| SINVVYSRGKSMGVL | 141 | P55895 | |
| VLGSMSTRIVNGAYK | 466 | Q6VN20 | |
| VGDQLQRTSKVYARM | 561 | Q9H2T7 | |
| QRTSKVYARMSEVLG | 566 | Q9H2T7 | |
| SGVEVFMVYNRTRVK | 46 | Q9ULC6 | |
| VGQVEISALSLMYRK | 101 | Q01804 | |
| EQSVGKTSLITRFMY | 21 | P20340 | |
| EQSVGKTSLITRFMY | 21 | Q9NRW1 | |
| VMRITVGVDGSVYKL | 401 | P35557 | |
| MGVIYRKALVITNSV | 386 | O15438 | |
| MSTVLYNRKEGRQVG | 526 | Q96RS6 | |
| GIYVVTVVGNLSMIT | 46 | Q6IF36 | |
| YRAIMAIVVSRSGNT | 521 | Q6IWH7 | |
| IFRYTGIRNKSSMVV | 1096 | Q6IE37 | |
| YTKALGEMVVQQESR | 206 | Q96K12 | |
| SSILVNKYGSRIVMI | 76 | P53985 | |
| VSYTVILMTLRSQAG | 216 | Q8NGI4 | |
| TVTAMDVVYALKRQG | 81 | P62805 | |
| TVTAMAVVYVLKRQG | 81 | Q99525 | |
| NATRVGMVNYASTVK | 76 | P21941 | |
| SGNVYILKGMIDQIS | 431 | Q6P0N0 | |
| QGIVIAMTTITKYTQ | 131 | Q4G0Z9 | |
| NVRALTKGVQAVMGY | 601 | Q9H089 | |
| NRVTIMGIYSIKKFG | 261 | P33992 | |
| TKGQVTTGQYRMLAK | 296 | Q16665 | |
| KTQVTVQYMQDRGAV | 181 | P31153 | |
| STQIIGRAMYQRAKE | 396 | Q9NR71 | |
| MKYINTTLVSRIGSV | 271 | Q9BVA6 | |
| EYVGNVIKMIQTRGR | 716 | O95786 | |
| GARKIYAVEASTMAQ | 206 | Q86X55 | |
| GVSRSATIVIAYLMK | 411 | Q9Y6W6 | |
| ETIYAQKFQGRVTMT | 76 | A0A0C4DH33 | |
| TMDVKRQITANEVYG | 2751 | Q9Y6V0 | |
| SVNKTGTMYGVIVRS | 161 | O75051 | |
| LTSVYGTVVMNRTVL | 376 | O60486 | |
| ARSIQMAVQGSIIKY | 146 | A8MYZ0 | |
| YTTILTNSRIIQMGL | 141 | A6NGY5 | |
| YTTILTNARIAKIGM | 146 | Q8NH61 | |
| KSGRILSQVMYTLFQ | 691 | Q13370 | |
| VQKLVTEMGTYATQS | 511 | P53618 | |
| QMQLTTGVEYIVTVK | 71 | Q9H114 | |
| IKIMDVGQSYVVNRV | 216 | Q16877 | |
| ILSMNGLSYGVIRVN | 696 | Q9P265 | |
| ILVGVMGTTAYQKRA | 746 | A0A1B0GTW7 | |
| GVTSLYKGFNAVMIR | 261 | O43772 | |
| GVLLYKQVMEGRVTF | 306 | Q9UJY4 | |
| ATYVNRESAIKGMIR | 476 | P34903 | |
| ARKEYTVGETVNLMS | 411 | Q92887 | |
| GVTTQGVKSLLTSMY | 2261 | P00451 | |
| FKRATTLGSYTVQMV | 1101 | Q6ZVL6 | |
| KNGIVVSRIGVKMYA | 5016 | P98088 | |
| KYTGIRNKSSMVVID | 1336 | Q6IE36 | |
| SMVARTQTVRGTLAY | 376 | P51617 | |
| AMVRLGLQYSQGLVS | 206 | Q9UI10 | |
| TLAGRLVMTKVNAVY | 521 | P42694 | |
| LRKYVTTMVCVAVNG | 186 | Q9NX62 | |
| GEEGVRVYSQLTMQK | 671 | Q9H6S3 | |
| SNVYVVTQGRKLYGM | 281 | Q14451 | |
| GKVRAVIGSTYMLTQ | 396 | Q14764 | |
| GETMGQVTEKLQLTY | 536 | Q13797 | |
| NKVTRIQSMNYGTIK | 16 | Q99572 | |
| EVSIIQSMGYRNRAK | 121 | P38398 | |
| MYSQRFGTVQREVKG | 1 | Q96M91 | |
| LTRGQAVVQYMKIVE | 236 | Q9Y2L6 | |
| GSMVQVYEQVRAKFT | 2471 | Q8NCM8 | |
| RGAIMVYIKVTVQTD | 96 | Q6ZP68 | |
| TGKISRMYNIDAVQA | 366 | A8MPY1 | |
| LMVTCTVYAIKARGV | 761 | O15303 | |
| RKGNYVADLGAMVVT | 321 | O60341 | |
| ASVEGYLRKVEMSIQ | 461 | Q6ZP82 | |
| KGYVRTQMSGNEVSR | 251 | P13765 | |
| IMEERIQTSGSNYKT | 131 | Q96P09 | |
| STNTGKAMTYVREKI | 516 | Q99715 | |
| GTIVITYSMKAGIQT | 631 | Q8TDB6 | |
| VQFSMVKVSEGKYRV | 221 | Q8NHY3 | |
| GVIVYEVKNNSRIAM | 571 | Q68DX3 | |
| EKYSVATQIVMGGVT | 46 | Q8IVP5 | |
| QKYGRIIMTSSASGI | 141 | P51659 | |
| RVANAVSVKGIYKQM | 386 | P55211 | |
| EVRQVGSYKKGTMTT | 101 | Q12905 | |
| GLYMQSVVDAIKRSS | 341 | Q3B7J2 | |
| LKAYIRSQTGVQILM | 391 | Q9NWK9 | |
| VREYLMAKGVCSVSQ | 146 | Q58HT5 | |
| GKLTYLADRVQMVSR | 446 | Q5T5S1 | |
| ITITGIKYVVDTGMV | 361 | Q9H6R0 | |
| IQVSEESYRVLSKMG | 1206 | O60503 | |
| AYNTFQVTTGGMVLK | 201 | P02746 | |
| REKYIQEARTMGSTI | 716 | Q6IQ26 | |
| QRRALETMIKTYGQT | 3396 | Q99698 | |
| MTSSPVSRVVYNGKR | 1 | C9JLW8 | |
| QRTMKYTTATGRNIT | 36 | Q96RQ3 | |
| RIYITDGNMQLTVLT | 781 | O00754 | |
| ERKPRVTGVTNYVMQ | 241 | Q8IWC1 | |
| MATGTRYAGKVVVVT | 1 | Q9BPX1 | |
| MEYLIKTGSERVSQQ | 81 | Q9Y6I3 | |
| VVAIQGVQTKLYLAM | 111 | Q92913 | |
| LGSYVINGRTKAMVA | 271 | Q96KS0 | |
| RSIGMVEVNTVDKYQ | 956 | P51530 | |
| GISRSVTVTVAYLMQ | 296 | Q16828 | |
| RQRGITIQSAATYTM | 96 | Q96RP9 | |
| NMGGKSTYIRQTGVI | 671 | P43246 | |
| MRVGLVAYSNETKVI | 266 | A6NMZ7 | |
| LKIETRYVSMGQGQE | 4066 | Q8TE73 | |
| KYQVAKMVQGRVTEV | 271 | Q5VU65 | |
| MGTSVLTTGYLLNRQ | 21 | P17540 | |
| YGAIVRAVLRMQSTT | 221 | O76001 | |
| SGMRIKTAVIGAVYR | 391 | P33527 | |
| NITVTMYITIGTRNL | 186 | Q9ULK6 | |
| GTLMAVKQVTYVRNT | 1266 | Q13233 | |
| KQVIVMKRSLGVGYA | 1036 | Q13423 | |
| YTVRVEDQKTMRGNV | 126 | O60469 | |
| TALMVAAQKGYTRLV | 146 | Q8TC84 | |
| GIRAKAVSQDMVIYS | 81 | Q9HBJ0 | |
| YAVDMQVLRNGTKVV | 161 | Q92777 | |
| MRTNGVIKTYNIFSD | 4091 | O75445 | |
| EMSTVINNTRGIIFY | 516 | Q96JX3 | |
| SYIQMLNGVSVTTAV | 116 | Q96GJ1 | |
| RGKILVSLMYSTQQG | 551 | Q9Y2J0 | |
| QGSTMIYLKAIQGIL | 181 | Q93075 | |
| QFGGKSSVEMYRQVL | 336 | Q15147 | |
| SVITVKNLRMAIGYL | 341 | Q9UKY4 | |
| NGQKMYGKIIRVTLS | 396 | Q9UKA9 | |
| IGYQTREVMCINKTG | 321 | Q9UPZ6 | |
| MQTLGSYGTIVLVRI | 916 | O15056 | |
| LGVIYTRNKMNGTLT | 161 | Q8NBX0 | |
| AYVTVGGITSVIKLM | 276 | Q8NBX0 | |
| RITGKMVATASYEAV | 486 | Q14934 | |
| RLAYSLGMTESQVKV | 171 | A6NJ46 | |
| MINGVVKAYKESRVA | 451 | Q8IVG5 | |
| LSTQTIREMYALTQG | 311 | Q02127 | |
| TAVKTAETGYMQRRL | 861 | O14802 | |
| GTIIIQNIGAMSSYL | 126 | Q8IZM9 | |
| LTEVNKTGTQYLLRM | 76 | P35237 | |
| GGQRIQVYMSVLSLI | 146 | Q2M3M2 | |
| VYGRTQMTLTFQKEV | 166 | Q8WVM0 | |
| YGVRTQEIKQGMQRL | 296 | Q8NH54 | |
| YKLVIFTNQMSIGRG | 211 | Q96T60 | |
| KQIKRMVSSYVGENA | 106 | P55809 | |
| NSSKIVIVMEYASRG | 121 | Q9H093 | |
| TQYVRDTVVGTMGLK | 146 | Q8N6T7 | |
| GSIVQLSQSVTAYMV | 511 | Q96JT2 | |
| VITSQGTVVKYMLDG | 1286 | Q6Q759 | |
| GTVVKYMLDGSTQIL | 1291 | Q6Q759 | |
| GTIQMKSTDILYRLQ | 136 | Q68CK6 | |
| VQTKQVYDAVGMLGI | 66 | Q9BYT8 | |
| RVGQMTKTYNDIDAV | 101 | Q9UPV9 | |
| ILGTDRVEQMTKTYN | 96 | O60296 | |
| GNMVRVVAKNYGVSI | 396 | Q6NUS8 | |
| NVIKTGVRMISLSYS | 401 | O43242 | |
| AQVVGERYGSKKSMV | 1126 | P10745 | |
| YTMSEINIVGRITLN | 2451 | O60673 | |
| QTQTTYRGIVDCMVK | 31 | Q8N413 | |
| KYITTIAGVMTLSQV | 231 | P25445 | |
| MKVIQGLYSGVTTVE | 41 | P23921 | |
| ETGYIQRRLIKSMES | 856 | P24928 | |
| SQIALEYGQAMTVRV | 31 | Q9BV90 | |
| KMGDRSVYNENTSVV | 131 | Q7Z5A4 | |
| AKNSYRMVVLGASRV | 16 | Q96D21 | |
| YGRKDRINSIMSVVT | 691 | Q9UQD0 | |
| TTDQVYQAIAAKVGM | 296 | Q96L92 | |
| KASTVGTYAQIMTVV | 4201 | Q86WI1 | |
| SRGQEVYVKKTMGRL | 986 | Q02763 | |
| MAAAGVVSGKIIYEQ | 1 | Q8TC07 | |
| IVSMTADKQNGTVYT | 426 | Q9UKN8 | |
| SEGGTRVVKLMYKNR | 1081 | Q9ULM0 | |
| VGAMNQYRTRTLSIT | 471 | Q9BVS4 | |
| VGMTTTGAAKYRQIL | 981 | Q9P2E3 | |
| MYGNVVVTSIGQLVL | 236 | Q96NZ8 | |
| VRNGLQIKGQAMTYV | 686 | Q6ZT12 | |
| TSVVKDSQVGTVNYM | 676 | P33981 | |
| VKRQMLYVGSRLGVA | 501 | Q9NS98 | |
| GKVMRSYKATIQQTL | 366 | Q64LD2 | |
| AQEVTRKYQEMTGQV | 131 | Q92748 | |
| EGKNIIVIMSSAGYI | 2056 | Q5T4S7 | |
| AYIIAKVQRNGSAAM | 461 | P08575 | |
| LYISVMQQDVTVGRS | 156 | P51811 | |
| TQYRQMKRGSLGVLT | 1906 | Q9P2D8 | |
| SVNVKKTILEMRYGA | 431 | Q5R3F8 | |
| TLGMTVKVTYRNFTE | 5171 | Q9UKN1 | |
| VTMVTSKNGGIYLLA | 216 | Q6IA69 | |
| GANMRTYLLEKSRVV | 236 | Q9Y4I1 | |
| GANMRTYLLEKSRVV | 236 | Q9ULV0 | |
| LVTGTNVYITRAQLM | 371 | Q96RE7 | |
| MLETVRIRQSGYSSK | 941 | B2RTY4 | |
| VYQRAVMAVGSLTIN | 501 | Q12879 | |
| GYQMSTRLKIVTIHQ | 391 | Q05586 |